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SUMMARY
ErbB-2 is a member of the family of epidermal growth factor receptors, which shows 
an oncogenic mutation in the rat gene neu, Val664Glu in the transmembrane domain 
that causes permanent dimerisation and subsequently leads to uncontrollable cell 
division and tumour formation. We have obtained the α-helical structure of the 
mutant transmembrane domain dimer experimentally with site-specific infrared 
dichroism (SSID) based on six transmembrane peptides with 13C18O carbonyl group 
labelled residues. The derived orientational data indicate a local helix tilt ranging 
from 28°±6° to 22°±4°. Altogether using orientational constraints from SSID and 
experimental α-helical constraints while performing a systematic conformational 
search including molecular dynamics simulation in a lipid bilayer, we have obtained a 
unique experimentally defined atomic structure. The resulting structure consists of a 
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right handed α-helical bundle with the residues Ile659, Val663, Leu667, Ile671, 
Val674 and Leu679 in the dimerisation interface. The right handed bundle is in 
contrast to the left-handed structures obtained in previous modelling efforts. In order 
to facilitate tight helical packing, the spacious Glu664 residues do not interact directly 
but with water molecules which enter the bilayer. 
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INTRODUCTION 
ErbB-2 is an epidermal growth factor receptor involved in the mediation of cell 
growth and differentiation 1; 2. ErbB receptors are composed of an extracellular ligand 
binding region, a transmembrane region and a cytoplasmic tyrosine kinase. Activation 
of the tyrosine kinase occurs by ligand induced dimerisation, a generally accepted 
activation pathway for all receptor tyrosine kinases 3. The ErbB-2 receptor in 
particular is activated by heteromeric association with other ErbB receptors which 
explains the fact that no high affinity ligand for ErbB-2 has been found 4. The rat 
oncogene neu encodes a mutant ErbB-2 receptor, which contains a single Val664Glu 
mutation in the transmembrane domain 5. This mutation causes permanent association 
and activation of ErbB-2 that leads finally to tumour formation 6; 7. Previous 
experimental studies using NMR and infrared spectroscopy have provided evidence 
that the transmembrane domain of ErbB-2 is a dimeric α-helical bundle and that the 
Glu664 residue is protonated and strongly hydrogen bonded 8. Based on this 
observation a model has been presented that involves hydrogen bond mediated 
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association of the two Glu residues as the major factor for permanent dimerisation of 
the mutant transmembrane domain 8; 9. 
However, several studies using molecular dynamics (MD) simulations have suggested 
that this interaction may lead to unfavourable packing of the two residues and that 
helix deformations are required to facilitate the hydrogen bonding thus disfavouring 
such a model 10; 11. More recent studies using MD simulations have suggested that 
water molecules enter the bilayer and interact with Glu residues and that the 
transmembrane domain shifts position to allow interaction of these residues with 
water 12; 13; 14.  
Ultimately, only high resolution structural studies using the transmembrane domain in 
lipid bilayers are able to resolve these discrepancies. However, applications of high-
resolution techniques such as x-ray crystallography and NMR spectroscopy to 
membrane proteins face enormous difficulties resulting in far fewer known membrane 
protein structures compared to water-soluble proteins. Here we use the novel method 
of site-specific infrared dichroism (SSID) 15; 16 combined with a systematic 
conformational search using experimentally constrained MD simulations for the first 
time in a lipid bilayer/water system. This method has been successfully employed in 
previous studies using in vacuo MD simulations for example for the M2 proton 
channel of the Influenza A virus 17, the CM2 domain of the Influenza C virus 18 and 
the mammalian MHC associated invariant chain 19. The SSID method involves the 
use of several synthetic peptides, in which one residue has a 13C=18O labelled 
carbonyl bond 20. The peptides are incorporated into liposomes, which are studied as 
oriented lipid multilayers with attenuated total reflection Fourier-transform infrared 
spectroscopy (ATR-FTIR). The helix tilt and rotational pitch angle of a particular 15; 21 
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residue obtained from SSID are used as additional energy terms in MD simulations 
systematically exploring the helix-helix interaction. 
 
RESULTS 
FTIR measurements – Typical FTIR spectra of the amide I region for each labelled 
peptide are shown in figure 2. Please note that no band sharpening technique like 
Fourier self-deconvolution has been applied. As can be clearly seen, the amide I 
absorption band at 1658 cm-1 is a symmetrical and non-shouldered peak, indicating 
that a predominantly α-helical structure is adopted by the peptide in the lipid bilayer 
environment. Residual intensity at 1618 cm-1 corresponds to 13C=16O labelled 
carbonyl bonds, because the amino acid does not exchange to 100% with H218O. The 
absorption band  at 1594 cm-1 represents the 13C=18O label 20; 22, confirming that the 
labelling procedure was successful in all cases.  As shown in figure 2, spectra were 
recorded at infrared radiation polarised parallel and perpendicular with respect to the 
plane of incidence, which produced a dichroic ratio in the range of R= 2.4 to 4.2 for 
the amide I absorption band, depending on sample order, and in the range of R= 2.4 to 
19.6 for the isotopic label absorption band, depending on position and sample order. 
In each instance, the dichroic ratio for the isotopic label was different from the amide 
I peak indicating oligomerisation.  Table 1 shows the resultant orientational data as 
defined in Figure 1A calculated from the SSID theory 15; 21. There is a tendency of 
variation in the local tilt ß of the helix along the peptide strand, being β = 28°±6 at 
Ile659/Ile660 and β = 22°±4° at the Val675/676 labels, although the variation is 
within the experimental error. At positions closer to the centre of the peptide strand 
(Leu667/Leu668) the helix adopts a local tilt of β = 25°±8°. 
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Molecular Dynamics Conformational Searching – MD simulations of 36 different 
rotational orientations with left-handed and right-handed crossing angle and 
simulation at four different random initial atom velocities produced 288 different 
peptide structures in a DMPC lipid bilayer/water system.  Figure 3 shows the resulting 
rotations of the initial structures and their respective energies following MD 
simulation. Clustering into categories of similar structures (as described in 
experimental procedures) followed by averaging produced seven structures, of which 
two were energetically unstable (figure 3). Of the remaining five structures, structure 
5 has the closest correlation to the experimental rotational pitch angles from the 
infrared data (table 2). Altogether eight substructures contributed to this cluster 
average, which is shown in figure 4. The α-helices remain close together although no 
interhelical distance restraints have been applied during the simulation. The structure 
in figure 4 reveals a right-handed α-helical bundle with a crossing angle of ~50°. The 
structure is tightly packed, displaying the classic ‘knobs into holes’ arrangement 
(figure 4B) 23.  The dimerisation interface between the helices is composed of Ile659, 
Val663, Leu667, Ile671, Val674 and Leu679. The bulky aromatic Phe669 groups are 
on the exterior of the complex, minimising steric hindrance and allowing tight 
packing to occur. By comparison, the Phe658 groups are near to the interhelical 
interface, but their arrangement does not appear to cause deformation of the helices. 
There also appears to be an interaction between one Thr662 residue and the backbone 
carbonyl oxygen of the Phe658 residue of the same helix.  There is no direct 
interaction between Glu residues, as they are not in such an arrangement, but instead 
an interaction between these side-chains and water molecules, which have entered the 
bilayer during simulation, was observed (figure 4C). No other water molecules were 
capable of entering the lipid region other than those interacting with Glu residues. 
 5
ErbB-2 structure 
DISCUSSION 
The FTIR data clearly indicates that the ErbB-2 peptide is in an α-helical 
conformation and the labelled sites also adopt this particular secondary structure 
(indicated by their absorbance at 1594 cm-1). Dichroic ratios vary in each FTIR 
spectrum for both the amide I peak and for the label peak. For the amide I peak these 
differences are solely the result of random variations in the sample order (which is 
taken into account in the calculation of the orientations 21). For the label, the extra 
factor of position of the 13C=18O bond must be taken into account (as different 
positions will have different tilts and rotations). The difference in the dichroic ratios 
of the amide I peak and the labelled peak indicate oligomerisation. The variations of 
the helix tilt are almost within the margin of error, although a trend for lower helix 
tilts from N to C terminus may be established. 
Following the constrained MD search, the resulting structure does not show the 
presence of inter-helical Glu hydrogen bonds. The interaction seen in figure 4 
involves water molecules, which interact with the Glu residues. The rotation at which 
this interaction can occur also appears to allow tight helical packing, as the structure 
corresponds fairly well to the conventional ‘knobs-into-holes’ pattern of α-helical 
packing 23. This is in accordance with previous unconstrained molecular simulation 
studies, which suggest that the direct Glu-Glu interaction is incompatible with 
favourable packing 10; 11. NMR studies using glutamine residues in place of the Glu 
have also indicated that the direct interaction is probably not adopted 24. 
The adopted rotation may be a balance between these two factors; as the Phe658 
residues are allowed to stack without causing disruption to the helical geometry, 
whilst Phe669 residues can point away from the complex. The interfacial motif 
observed is fairly typical of helical packing in a lipid bilayer and will allow tight 
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packing to occur. At the same time, both the Glu664 and Thr662 residues are able to 
form hydrogen bonds, thereby stabilising the polar groups in their apolar environment. 
The other previously suggested rotation, that of interaction between Glu residues and 
the carbonyl backbone of the opposing peptide chain 9, is not observed either. This 
requires a different rotational pitch angle to that adopted by the structure obtained in 
this study. Neither is there any evidence in the structure of significant deformation of 
the α-helical complex, suggested by previous study as a means to allow potential sites 
for Glu hydrogen bonding interactions 10. 
Water molecules have been previously suggested as an important factor in the 
dimerisation of mutant ErbB-2 by long MD simulations on selected rotations of the 
complex 12; 13; 14. It is still unclear exactly how or why water molecules enter the 
bilayer. But previous research has suggested that the α-helical complex itself also 
shifts position slightly in order to move the Glu residues closer to the water molecules 
and the polar regions of the lipid molecules. This should increase the likelihood of 
such an interaction occurring.  
It is still unclear exactly how the Glu residue mutation results in permanent 
dimerisation of the complex. One possibility is the presence of a different 
conformation in a fluid-state hydrated bilayer, as opposed to the partially dry gel-state 
bilayer studied in the experiment (the bilayer in the MD simulation is in the fluid-
state). 
Another possibility is that wild-type and mutated ErbB-2 have different dimerisation 
motifs and the Glu has some role to play in stabilising the mutated dimerisation, such 
as the water interaction. This is supported by recent experimental studies which 
indicate that the Glu mutation has little or no effect on the dimerising ability of 
ErbB-2 25. A proposed reason for this is that the Glu mutation allows the helix to 
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adopt different orientations to those adopted by the wild-type, and it is this that 
promotes constant dimerisation. There also has been the suggestion that the wild-type 
ErbB-2 possesses two dimerisation motifs, an active and inactive form, and that the 
mutation shifts the equilibrium towards the active form 26. 
In order to explore these hypotheses further, the transmembrane domain of the wild-
type ErbB-2 peptide would need to be structurally elucidated in a similar way. This is 
practically more difficult, if extracellular ligand binding is required for dimerisation, 
although there is some evidence that the wild-type transmembrane domain can self-
associate without its extracellular region 25.  
The right-handed crossing angle between the α-helices is in contrast to previous MD 
simulation studies, which have suggested a left-handed crossing for the mutant 
ErbB-2 complex 10; 11. However, these studies did not include experimental restraints. 
Some left-handed structures were produced in our own study, but none of these fit the 
infrared data as well as structure 5. Right-handed crossing was observed using two 
interhelical distance constraints between 13CH2 Gly665 on helix 1 and 13C=O Glu664 
and 13CH2 Gly665 on helix 2 from solid-state NMR studies with an in vacuo 
minimisation and molecular dynamics procedure 24,  although the dimerisation motif 
is different in this study. We analysed the model produced from this study and 
obtained rotational pitch angles of ω = 74° for Ile659 and ω = 155° for Leu667 sites, 
which differ from our own IR data by 150º and 163º respectively (the solid-state 
NMR model does not include the segment containing the Val675 residue). Key 
differences between this study and our own work include the mutation of Glu to Gln, 
which can alter the preferred orientation due to different side-chain interactions. 
Additionally the simulation in the previous study was performed without explicit 
representation of lipid and water molecules, which may also affect the results.  
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The role of the lipid membrane itself also requires further investigation. The DMPC 
lipid bilayer used in this study has been used in all previously reported MD simulation 
studies 11; 12; 13; 14 (apart from those performed in vacuo 10). DMPC was also the 
bilayer of choice in earlier NMR studies 8, although more recent work has looked at 
the protein in a lipid bilayer composed of the partially unsaturated POPC molecules 24. 
The composition of the bilayer may have an effect on the stability and orientation of 
the transmembrane peptide complex, both sterically and energetically. Naturally 
occurring membranes possess various types of lipid chains and ideally should be used 
for such studies, but so far only MD studies focussing on binary mixtures begin to 
emerge. 
 
CONCUSIONS 
This is the first study of the mutant ErbB-2 transmembrane domain to yield a high 
resolution structure based on experimental constrains and MD simulations in a lipid 
bilayer/water system. This research demonstrates the necessity to combine simulation 
and experiment in order to investigate the structure of transmembrane helical bundles. 
This allows for the inclusion of specific experimental data, directly relevant to the 
system in question, into the computational simulations. 
Furthermore, this work demonstrates the usefulness of a conformational search in a 
lipid bilayer which was here attempted for the first time compared to earlier in vacuo 
searches 10. But it is clear that, even with explicit representation of solvent and lipid 
molecules, energetics alone cannot accurately determine the actual structure of the 
domain in question. Only by combining simulation and experimental data such as 
site-specific IR dichroism can one hope to produce accurate models out of many 
energy minima resulting from experimentally unconstrained simulation. 
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This work should support further modelling research of the full length ErbB-2 
receptor assembling the known crystal structures of the extracellular and intracellular 
domains 27 with the obtained transmembrane domain structure in order to understand 
the biology of Erb-B receptors in disease processes. 
 
MATERIALS AND METHODS 
Amino Acid Labelling – 1-13C amino acids were obtained from Cambridge Isotope 
Laboratories (Cambridge, MA) and labelled with 18O at the carboxyl group using 
H218O (95% enrichment – Campro Scientific, Veenendaal, Holland) at low pH as 
described elsewhere 20. The 9-fluorenylmethyl-oxycarbonyl (Fmoc) protecting group 
has been added following literature procedures  28 by reaction with Fmoc-ONSu using 
triethylamine as a base (sodium hydroxide in the case of leucine). The products of 
each reaction step were analysed by mass spectrometry. 
 
Peptide Synthesis – Six peptides of the transmembrane domain of ErbB-2 (residues 
652-685 RASPVTFIIATVEGVLLFLIL VVVVGILIKRRR) were obtained from 
Keck Laboratories (Yale University, USA) with one 13C=18O labelled amino acid 
residue each in the positions indicated in boldface italic in the sequence. The resulting 
peptides were purified as described elsewhere for analogous transmembrane peptides 
19; 29. Briefly, the peptide was dissolved in trifluoroacetic acid and purified by 
reversed phase chromatography (Jupiter 5C4-300 Å column, Phenomenex, Cheshire, 
UK). Peptide elution was achieved with a linear gradient to a final solvent 
composition of 5 % H2O, 38% acetonitrile and 57% 2-propanole. All solvents 
contained 0.1% (v/v) trifluoroacetic acid. After lyophilisation of the pooled fractions 
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the peptide was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol, containing 
dimyristoylphosphocholine (Sigma, UK), to a peptide to lipid ratio of 1:30 (w/w)  
 
Preparation of Proteoliposomes – Proteoliposomes were prepared by rotational 
evaporation of the organic solvent followed by addition of water to obtain a lipid 
concentration of 10mg/mL. Liposome preparations were then sonicated and freeze-
thawed three times and stored frozen. The pH of the resulting preparations was 
approximately 4. 
 
Attenuated Total Reflection Fourier Transform Infrared Spectroscopy – 
Approximately 120 µL of proteoliposome suspension was deposited onto a 
trapezoidal Germanium internal reflection element (50 mm x 2 mm x 20 mm). After 
the removal of bulk water in a stream of nitrogen the FTIR spectrum was taken as an 
average of 1000 interferograms using a Bruker Tensor FTIR spectrometer (Bruker 
Optics, Coventry, UK) containing a high sensitivity liquid nitrogen-cooled MCT/A 
detector. Each spectrum was taken in the 4000 to 1000 cm-1 range of the 
electromagnetic radiation at a resolution of 2 cm-1 per data point. Spectra were 
recorded at parallel and perpendicular polarisation and the dichroic ratio was 
calculated as the ratio between the integrated absorption of parallel and perpendicular 
polarised light for the amide I absorption band centred at wavenumber 1658 cm-1 and 
for the 13C=18O absorption band centred at 1594 cm-1. For each of the six peptides at 
least three independent measurements were taken. Altogether twenty-five spectra 
were obtained and analysed. 
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Data Analysis – The resulting dichroic ratios were analysed for each pair of adjacent 
labels using the theory of (SSID) as presented initially by Arkin et al. (1997) 15 with 
modifications by Kass et al. (2004) 16 resulting in the local helix tilt β and the 
rotational pitch angle ω of the labelled carbonyl bond (for definition of the 
geometrical parameters see figure 1). Briefly, the theory of SSID allows to deduce the 
orientational parameters of a peptide α-helix from the experimental dichroic ratio of 
the unlabelled amide I absorption band (Rhelix) and the dichroic ratio of the absorption 
band caused by the labelled residue (Rsite). Rhelix is a function of the helix tilt angle ß 
and the distribution around this tilt angle caused by sample disorder and mosaicity. 
Rsite depends additionally on the rotational pitch angle ω. In order to obtain the 
geometrical parameters ß and ω an additional label is required at a position next in 
sequence such that the rotational pitch angle is ω+100º assuming a canonical α-helix, 
which is a valid assumption over such a short distance. The four resulting non-linear 
equations can be solved by standard numerical methods. 
Note that contrary to the conventional analysis of dichroic ratios 30 an exact helix tilt 
can be obtained, even if the sample is partially disordered, while conventional 
analysis only yields a maximum tilt angle. The angle θ between the labelled C=O 
bond and the z-axis was calculated from the equation 21: 
( )o17cossinsincoscoscos +−= ωβαβαθ  
Where α is defined as the angle between the transition dipole moment and the 
molecular director, given as 38° in α-helices 31. All calculations were carried out with 
Mathematica 5 (Wolfram Research, Champaign, IL). Typically seven results were 
averaged. 
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Systematic Molecular Dynamics (MD) Searching – The conformational search and 
simulations were performed using the CHI suite of programs 32 for CNS-SOLVE 33 
combined with the GROMACS molecular simulation software 34; 35. CHI was used to 
create dimeric starting structures by rotating the helices through 10° increments for 
both left and right-handed dimers (crossing angle ±25°). Each structure was created 
four times (to allow MD simulations with 4 different random velocities) to produce a 
total of 288 starting structures. GROMACS was then used to perform MD simulations 
at 300 K. Each starting structure was placed in a pre-equilibrated bilayer of 128 
DMPC molecules 36. In-house developed software was then used to remove lipid 
molecules overlapping with the protein within a distance of 0.03Å. A hole within the 
bilayer was then created using 30ps of MD simulation using an outwards directed 
force on the lipid molecules 37. The bilayer was orientated such that the lipid/water 
interface was perpendicular to the defined z-axis of the overall system. Ten chloride 
counter-ions were added to neutralize the overall charge of the system and the 
resulting bilayer was then subjected to 100 ps of MD with the peptide atoms 
restrained in their current positions, followed by unrestrained energy minimisation. 
The system was then subjected to 200 ps of unrestrained molecular dynamics 
followed by energy minimisation. Simulations were performed with the GROMACS-
87 forcefield 38 containing additional parameters for lipid molecules 39; 40. Bond 
lengths were constrained with the LINCS algorithm 41 allowing a time-step of 2 fs. 
Temperature and pressure were controlled using the Berendsen coupling scheme with 
a time constant of 0.1 ps for both temperature coupling and pressure coupling 42. All 
simulations were carried out with periodic boundary conditions. Electrostatic 
interactions were treated with a twin cut-off range of 1nm/1.8 nm and van der Waal’s 
interactions were cut-off at 1nm. 
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Each simulation was carried out with experimental constraints on the angle of the 
labelled C=O carbonyl bonds to the z-axis with a force constant of 5000 kJ mol-1. 
Local tilts were also taken into account by constraining the angle to the z-axis of a 
vector defined by the Cα atoms of the labelled residue at position i and residue at the 
relative i+7 position. Further experimental constraints accounted for the α-helical 
secondary structure of the peptide (confirmed by our FTIR and previous experiments 
8) by allowing distances between carbonyl oxygens and amide hydrogens of residues i 
and i+4 in the transmembrane region to vary freely between 1.6 nm and 2.3 nm and 
applying a harmonic potential outside these boundaries. Altogether twenty-nine 
constraints were placed on each of the peptides. 
Once the search had been performed, Cα root-mean-square-deviation (RMSD) 
comparisons were made between all resulting structures. Structures were then 
clustered according to their RMSD values. The adopted criteria for structure 
clustering were that of a maximum RMSD value of 2 Å between two structures. For a 
cluster to be created, a minimum of five structures possessing RMSD values within 
this limit was required. 
The structures contributing to this cluster were then used to create an average 
structure, which was subjected to MD simulation for 2ns in the DMPC, followed by 
energy minimisation. 
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FOOTNOTES 
# Abbreviations Used: FMOC – 9-flourenylmethoxylcarbonyl; DMPC – 
dimyristoylphosphocholine; FTIR – Fourier transform infrared; NMR – Nuclear 
Magnetic Resonance; RMSD – Root Mean Square Deviation, SSID – site specific 
infrared dichroism. 
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FIGURES 
Figure 1: (A) Definition of the helix tilt β, the rotational pitch angle ω and the angle θ 
representing the angle between a particular labelled amide I transition dipole moment 
and the z-axis. ω is defined as 0° when the transition dipole moment points in the 
direction of the helix tilt. The angle α is defined as 38° for all α-helices 31.  (B) The 
method of rotating the peptides by increments of the angle φ, resulting in the array of 
starting structures used for MD simulation. The angle Ω represents the helical 
crossing angle. 
 
Figure 2: Infrared spectra for each peptide containing a 13C=18O label in the position 
indicated in the top left. The amide I area is displayed, while the insert shows the 
magnified amide I absorption band of the label. 
 
Figure 3: (A) Polar plot of the energies of structures obtained from MD simulation of 
mutant ErbB-2 in dependence of the helix rotation angle φ. The distance from the 
centre indicates negative energy (E) in kJ/mol. Each individual structure is indicated 
by a triangle, while the clustered averages are shown as numbered circles. The arcs 
represent the movement of structures from their starting positions with respect to the 
helix rotation angle φ during the MD simulation. (B) The rotation of the helix dimer 
defined as φ=0. 
 
Figure 4: Structure of the ErbB-2 transmembrane domain obtained by SSID 
constrained MD simulations. (A) The structure in ribbon representation with Glu 
residues displayed. (B) Spacefill rendering of structure, Glu in black and labelled 
residues in dark grey. (C) A detailed view of the Glu interaction with water molecules. 
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(D) View of the Glu residue packing from top of helix. All figures have been created 
with VMD 43. 
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TABLES 
Table 1: Local helix tilt angle β, rotational pitch angle ω and the resulting calculated 
angle of C=O bond to z-axis θ, from dichroic ratio comparisons between peptides 
with neighbouring labels.   
 
Label β θ ω 
Ile659/Ile660 28.1°±6° 56°±3° 284°±8° 
Leu667/Leu668 25.2°±8° 63°±6° 318°±14° 
Val675/Val676 21.9°±4° 59°±2° 327°±10° 
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Table 2: Comparison of rotational pitch angles obtained from infrared spectra to those 
possessed by the clustered average structures. The deviation of the rotation angles 
from the experimental values for each averaged structure is also shown for 
comparative purposes. This is calculated using the formula ( )∑ − 2modexp elωω . 
 
Label ωexp 1 2 3 4 5 
Ile659 284° 275° 152° 267° 255° 255° 
Leu667 318° 93° 313° 326° 344° 329° 
Val675 327° 203° 16° 69° 72° 307° 
Deviation  184° 142° 104° 112° 38° 
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